Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Ramadan

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Lancet (London, England)|October 25, 2001
Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trialD J Goldstein, K I Roon, W W Offen, et al.
Radiology|November 1, 1992
Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopyS R Levine, J A Helpern, K M Welch, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Lancet (London, England)|October 25, 2001
Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trialD J Goldstein, K I Roon, W W Offen, et al.
Radiology|November 1, 1992
Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopyS R Levine, J A Helpern, K M Welch, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
Pageof 6